April 25 (Reuters) – Hundreds of patients and advocates
packed a hotel ballroom in Hyattsville, Maryland, on Monday to
try to persuade advisers to the U.S. Food and Drug
Administration to support…
The post UPDATE 1-U.S. FDA panel meets to discuss Sarepta muscular dystrophy drug appeared first on NASDAQ.